Michael Joner
Latest contributions
All you need to know - Intracoronary imaging for vulnerable plaque
22 May 2026 – From EuroPCR 2026
This session provides a comprehensive overview of vulnerable plaque pathophysiology and the role of intracoronary imaging in its identification. It assesses treatment options, including the potential role of preventative PCI and intensive medical therapy, to guide clinical decision-making in managing plaque vulnerability.
TAVI vs. surgery - Are the latest long-term data creating a dilemma for aortic stenosis patients?
21 May 2026 – From EuroPCR 2026
This session critically evaluates the latest long-term data comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). It explores differing perspectives between surgeons and interventional cardiologists regarding valve durability and lifetime management, fostering a high-quality debate to achieve consensus within Heart Team discussions...
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.
Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection
20 May 2026 – From EuroPCR 2026
This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.
Registries and trials in TMVR
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of registries and clinical trials focused on transcatheter mitral valve replacement (TMVR). It presents data on annular and ventricular remodeling with the HighLife system, mid- to long-term valve performance, and innovations in transseptal TMVR using novel bioprostheses.
TAVI and coronary artery disease: we need the COMPLETE answer!
19 May 2026 – From EuroPCR 2026
Addressing the intersection of transcatheter aortic valve implantation (TAVI) and coronary artery disease, this session reviews contemporary surgical and interventional literature to elucidate current practices. It underscores the need for a large international randomized controlled trial to provide definitive guidance for managing patients with concomitant aortic...
Next generation TAVI procedural planning
19 May 2026 – From EuroPCR 2026
Explore the forefront of TAVI procedural planning, featuring innovations such as valve-in-valve techniques for sutureless valves, integration of artificial intelligence in heart team decisions, and advanced imaging-guided access methods. The session also examines clinical outcomes related to bicuspid anatomy and prosthesis-patient mismatch, providing a comprehensive view...
Editor's Choice Podcast by Eurolntervention
02 Apr 2026
Designed for specialists in interventional cardiology, this podcast delivers high-value educational content by featuring leading researchers published in EuroIntervention - your reference journal in coronary, valvular and structural interventions.
Featured research - Mitral valve interventions - Part 4
18 Nov 2025 – From PCR London Valves 2025
This research-focused session presents contemporary evidence and clinical outcomes related to mitral valve interventions. It includes data on transapical mitral valve-in-ring implantation from the European Tendyne registry, prognostic utility of CT-derived fatty muscle fraction in mitral TEER, and comparative outcomes between transapical TMVR and mitral TEER....
Hot topics in structural heart: addressing patients' unmet needs with EVOQUE TTVR and SAPIEN THV-in-THV
17 Nov 2025 – From PCR London Valves 2025
This session addresses emerging topics in structural heart disease by examining patient-centered solutions such as EVOQUE transcatheter tricuspid valve replacement (TTVR) and SAPIEN transcatheter heart valve-in-heart valve (THV-in-THV) procedures. It covers the latest data from Europe on redo TAVI, lifetime management strategies beginning with initial prosthesis...
Highlights in valvular heart disease research - The year in EuroIntervention
17 Nov 2025 – From PCR London Valves 2025
This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system...
TAVI in patients with concomitant valve and coronary artery disease
17 Nov 2025 – From PCR London Valves 2025
Focused on patients with concomitant valve and coronary artery disease, this session examines evaluation strategies for aortic stenosis burden, integrates recent trial data on combined TAVI and PCI, and discusses optimal management approaches in complex multi-valve disease scenarios through detailed case presentations and clinical outcomes.
The D-PACE scoring system Prediction of high-grade conduction disturbances after TAVI
16 Nov 2025 – From PCR London Valves 2025
Michael Joner and Francesco Saia discuss the newly developed D-PACE Score, a tool designed to predict delayed AV block occurring more than 24 hours after TAVI—an unmet clinical need given that current risk models focus mainly on early events. The next steps aim to refine the...
The expanding practice of LAAC today in case examples
01 Oct 2025
Watch this replay with M. Joner, M. Lange and B. Schmidt to understand current indications for left atrial appendage occlusion in clinical practice and so much more!
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Is DCB a new valid option for coronary revascularisation?
22 May 2025 – From EuroPCR 2025
This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...
How to handle the most clinically relevant challenges in TAVI
21 May 2025 – From EuroPCR 2025
This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...
TAVI for asymptomatic aortic stenosis after EARLY TAVI - TAVI and coronary artery disease after NOTION-3
21 May 2025 – From EuroPCR 2025
Critically assess the clinical implications of the EARLY TAVI and NOTION-3 trials with a focus on asymptomatic aortic stenosis and concomitant coronary artery disease. This session integrates recent evidence into patient-centered care pathways, offering case-based insights for optimizing timing and management strategies in TAVI patients.
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
How will EARLY-TAVI and NOTION-3 impact TAVI practice?
21 May 2025 – From EuroPCR 2025
When is the right time to perform TAVI—and how should coexisting coronary artery disease be managed? In this interview, Liesbeth Rosseel, Davide Capodanno, and Michael Joner tackle these two timely questions. They share key takeaways from the EARLY-TAVI trial, which demonstrated reduced rehospitalisation with early intervention...
Degenerated bioprosthesis and Bentall surgery: how to track and position the valve with an angulated ascending aorta conduit?
06 Feb 2025
Complex procedures, such as TAVI in patients with a degenerated bioprosthesis and a Bentall surgery history, demand meticulous planning. This case highlights the importance of computed tomography imaging to minimize procedural risks and explores the snare strategy for navigating anatomical constraints. Learn how this approach, adaptable to...
Author
Author
Author
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
Electrosurgery and leaflet modification: addressing an unmet need for transcatheter valve interventions
24 Nov 2024 – From PCR London Valves 2024
Electrosurgery and leaflet modification are revolutionizing transcatheter valve interventions, addressing unmet needs for patients who lack conventional treatment options. This video offers a deep dive into the clinical applications of these advanced techniques and equips you with the knowledge to implement them effectively.
You’ll discover:
- How electrosurgical tools,...
TAVI for today and tomorrow - What matters the most to patients?
28 May 2024
Watch the replay of this webinar with R. Hahn, K. Hayashida, M. Joner and S. Redwood on how to illustrate how TAVI would optimise the full spectrum of lifetime management to all patients and much more!
TAVI hotline: long-term registry data
15 May 2024 – From EuroPCR 2024
This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
Bioresorbable scaffolds - new evidence and clinical applications
09 May 2024
Watch this webinar with M. Haude, H. Garcia Garcia, M. Joner and B. Scheller on how to revisit the concept and new technology of BRS and much more!
TAVI: From simple to complex - LIVE case
20 Nov 2023 – From PCR London Valves 2023
This session explores two clinical cases, providing valuable insights into the essential components of a straightforward and efficient TAVI procedure. Find out more about the application of innovative devices to broaden the scope of aortic valve intervention, facilitating their integration into Heart Team discussions and daily...
Is only fixing functional mitral regurgitation in heart failure patients enough?
20 Nov 2023 – From PCR London Valves 2023
This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.
